Navaneethan, Sankar D.

Heart Disease and Stroke Statistics—2023 Update: A Report From the American Heart Association

Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Beaton, A. Z., Boehme, A. K., Buxton, A. E., et al. (2023) · Circulation

Cardiovascular Health and Risk FactorsHealthcare Systems and Public Health

Cited by 8,300

Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association

Tsao, C. W., Aday, A. W., Almarzooq, Z. I., Alonso, A., Beaton, A. Z., Bittencourt, M. S., Boehme, A. K., Buxton, A. E., Carson, A. P., Commodore-Mensah, Y., et al. (2022) · Circulation

Cardiovascular Health and Risk FactorsHealthcare Systems and Public Health

Cited by 5,987

Heart Disease and Stroke Statistics—2021 Update: A Report From the American Heart Association

Virani, S. S., Alonso, A., Aparicio, H. J., Benjamin, E. J., Bittencourt, M. S., Callaway, C. W., Carson, A. P., Chamberlain, A. M., Cheng, S., Delling, F. N., et al. (2021) · Circulation

Cardiovascular Health and Risk FactorsHealthcare Systems and Public Health

Cited by 5,784

Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 5-Year Outcomes

Schauer, P. R., Bhatt, D. L., Kirwan, J. P., Wolski, K., Aminian, A., Brethauer, S. A., Navaneethan, S. D., Singh, R. P., Pothier, C. E., Nissen, S. E., et al. (2017) · New England Journal of Medicine

Bariatric Surgery and OutcomesDiabetes Treatment and Management

Cited by 2,934

2024 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association

Martin, S. S., Aday, A. W., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., Baker-Smith, C. M., Barone Gibbs, B., Beaton, A. Z., Boehme, A. K., et al. (2024) · Circulation

Cardiovascular Health and Risk FactorsHealthcare Systems and Public Health

Cited by 2,800

Bariatric Surgery versus Intensive Medical Therapy for Diabetes — 3-Year Outcomes

Schauer, P. R., Bhatt, D. L., Kirwan, J. P., Wolski, K., Brethauer, S. A., Navaneethan, S. D., Aminian, A., Pothier, C. E., Kim, E. S. H., Nissen, S. E., et al. (2014) · New England Journal of Medicine

Bariatric Surgery and OutcomesDiabetes Treatment and Management

Cited by 1,901

Diabetic kidney disease: a report from an ADA Consensus Conference

Tuttle, K. R., Bakris, G. L., Bilous, R. W., Chiang, J. L., de Boer, I. H., Goldstein-Fuchs, J., Hirsch, I. B., Kalantar-Zadeh, K., Narva, A. S., Navaneethan, S. D., et al. (2014) · Diabetes Care

Chronic Kidney Disease and DiabetesDiabetes Management and Research

Cited by 1,153

Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis

Tangri, N., Grams, M. E., Levey, A. S., Coresh, J., Appel, L. J., Astor, B. C., Chodick, G., Collins, A. J., Djurdjev, O., Elley, C. R., et al. (2016) · JAMA

Chronic Kidney Disease and DiabetesDialysis and Renal Disease Management

Cited by 737

Metabolic Syndrome and Kidney Disease: A Systematic Review and Meta-analysis

Thomas, G., Sehgal, A. R., Kashyap, S. R., Srinivas, T. R., Kirwan, J. P., & Navaneethan, S. D. (2011) · Clinical Journal of the American Society of Nephrology

Chronic Kidney Disease and DiabetesDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 553

Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Clase, C. M., Carrero, J.-J., Ellison, D. H., Grams, M. E., Hemmelgarn, B. R., Jardine, M. J., Kovesdy, C. P., Kline, G. A., Lindner, G., Obrador, G. T., et al. (2020) · Kidney International

Potassium and Related DisordersParathyroid Disorders and Treatments

Cited by 498

Benefits and Harms of Statin Therapy for Persons With Chronic Kidney Disease: A Systematic Review and Meta-analysis

Palmer, S. C., Craig, J. C., Navaneethan, S. D., Tonelli, M., Pellegrini, F., & Strippoli, G. F. M. (2012) · Annals of Internal Medicine

Lipoproteins and Cardiovascular HealthChronic Kidney Disease and Diabetes

Cited by 359

Change in albuminuria and subsequent risk of end-stage kidney disease: an individual participant-level consortium meta-analysis of observational studies

Coresh, J., Heerspink, H. J. L., Sang, Y., Matsushita, K., Arnlov, J., Astor, B. C., Black, C., Brunskill, N. J., Carrero, J.-J., Feldman, H. I., et al. (2019) · The Lancet Diabetes & Endocrinology

Chronic Kidney Disease and DiabetesAcute Kidney Injury Research

Cited by 338

Executive summary of the 2020 KDIGO Diabetes Management in CKD Guideline: evidence-based advances in monitoring and treatment

de Boer, I. H., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., et al. (2020) · Kidney International

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 278

Executive summary of the KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease: an update based on rapidly emerging new evidence

Rossing, P., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., et al. (2022) · Kidney International

Chronic Kidney Disease and DiabetesDiabetes Treatment and Management

Cited by 274

Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease

Strippoli, G. F., Bonifati, C., Craig, M. E., Navaneethan, S. D., & Craig, J. C. (2006) · Cochrane Database of Systematic Reviews

Chronic Kidney Disease and DiabetesRenin-Angiotensin System Studies

Cited by 265

Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update

Navaneethan, S. D., Zoungas, S., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Liew, A., Michos, E. D., Olowu, W. A., Sadusky, T., et al. (2023) · Annals of Internal Medicine

Chronic Kidney Disease and DiabetesDiabetes Treatment and Management

Cited by 248

Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease

Chung, E. Y., Ruospo, M., Natale, P., Bolignano, D., Navaneethan, S. D., Palmer, S. C., & Strippoli, G. F. (2020) · Cochrane Database of Systematic Reviews

Chronic Kidney Disease and DiabetesHormonal Regulation and Hypertension

Cited by 157

Utilization Rates of SGLT2 Inhibitors and GLP-1 Receptor Agonists and Their Facility-Level Variation Among Patients With Atherosclerotic Cardiovascular Disease and Type 2 Diabetes: Insights From the Department of Veterans Affairs

Mahtta, D., Ramsey, D. J., Lee, M. T., Chen, L., Al Rifai, M., Akeroyd, J. M., Vaughan, E. M., Matheny, M. E., Santo, K. R. D. E., Navaneethan, S. D., et al. (2022) · Diabetes Care

Diabetes Treatment and ManagementHeart Failure Treatment and Management

Cited by 137

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes: A Mediation Analysis

Agarwal, R., Tu, W., Farjat, A. E., Farag, Y. M. K., Toto, R., Kaul, S., Lawatscheck, R., Rohwedder, K., Ruilope, L. M., Rossing, P., et al. (2023) · Annals of Internal Medicine

Chronic Kidney Disease and DiabetesHormonal Regulation and Hypertension

Cited by 109

Lifestyle-Induced Decrease in Fat Mass Improves Adiponectin Secretion in Obese Adults

KELLY, K. R., NAVANEETHAN, S. D., SOLOMON, T. P. J., HAUS, J. M., COOK, M., BARKOUKIS, H., & KIRWAN, J. P. (2014) · Medicine & Science in Sports & Exercise

Adipokines, Inflammation, and Metabolic DiseasesRegulation of Appetite and Obesity

Cited by 45

Chronic kidney disease, atherosclerotic plaque characteristics on carotid magnetic resonance imaging, and cardiovascular outcomes

Beddhu, S., Boucher, R. E., Sun, J., Balu, N., Chonchol, M., Navaneethan, S., Chertow, G. M., Townsend, R., Haley, W., Cheung, A. K., et al. (2021) · BMC Nephrology

Cerebrovascular and Carotid Artery DiseasesCardiovascular Health and Disease Prevention

Cited by 10